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M O L E C U L A R  B I O L O G Y
Molecular basis of tRNA recognition by the 
Elongator complex
Maria I. Dauden1*, Marcin Jaciuk2, Felix Weis1, Ting-Yu Lin2, Carolin Kleindienst3,  
Nour El Hana Abbassi2,4, Heena Khatter1, Rościsław Krutyhołowa2,5, Karin D. Breunig3, 
Jan Kosinski1,6†, Christoph W. Müller1†, Sebastian Glatt2†
The highly conserved Elongator complex modifies transfer RNAs (tRNAs) in their wobble base position, thereby 
regulating protein synthesis and ensuring proteome stability. The precise mechanisms of tRNA recognition and its 
modification reaction remain elusive. Here, we show cryo–electron microscopy structures of the catalytic subcomplex 
of Elongator and its tRNA-bound state at resolutions of 3.3 and 4.4 Å. The structures resolve details of the catalytic 
site, including the substrate tRNA, the iron-sulfur cluster, and a SAM molecule, which are all validated by mutational 
analyses in vitro and in vivo. tRNA binding induces conformational rearrangements, which precisely position the 
targeted anticodon base in the active site. Our results provide the molecular basis for substrate recognition of 
Elongator, essential to understand its cellular function and role in neurodegenerative diseases and cancer.
INTRODUCTION
Catalytic reactions and regulatory mechanisms of transfer RNA 
(tRNA) modification enzymes have a profound influence on intra-
cellular protein synthesis and in most of the cellular processes in all 
three domains of life (1, 2). In yeast, 11 of the 13 tRNAs carrying a 
uridine base in the wobble position (U34) are carboxymethylated 
(cm5) by the Elongator complex (3–5). This pivotal C5 substitution of 
U34 subsequently leads to the synthesis of 5-methoxycarbonylmethyl 
(mcm5), 5-carbamoylmethyl (ncm5), or 5-methoxy-carbonyl-methyl-2-thio 
(mcm5s2) by other enzymatic cascades (6). These modifications 
fine-tune the dynamic processes of tRNA binding, recognition, 
and rejection in the A site of the ribosome (7–9). Reduced levels 
of modified anticodons result in a codon-dependent decrease in 
ribosomal translocation speed during the elongation cycle and 
affect protein synthesis rates globally (10). Accordingly, cotrans-
lational folding dynamics of nascent polypeptide chains (11–13) 
are disturbed, ultimately inducing intracellular proteome ag-
gregation and proteotoxic stress (14–16). Therefore, genetic de-
pletion or specific mutations affecting the integrity and activity 
of the Elongator complex are associated with the onset of severe 
neurodegenerative diseases, intellectual disabilities, and cancer 
(13, 17–21).
The eukaryotic Elongator complex is composed of six highly 
conserved subunits (Elp1 to Elp6) that are all required for its full 
tRNA modification activity in vivo (22, 23). The fully assembled 
yeast complex comprises two copies of each of its six subunits that 
are arranged in the catalytic Elp123 (620 kDa) and the associated 
Elp456 (230 kDa) subcomplexes (24, 25). Within the symmetric 
Elp123 subcomplex (26, 27), Elp1 forms a homodimer via its 
C-terminal domain (CTD) and serves as a scaffold for Elp2 and
Elp3 subunits forming two lobes (26–28). The catalytic Elp3
subunit harbors a radical S-adenosyl methionine binding (rSAM)
and a lysine acetyl–coenzyme A (CoA) transferase (KAT) domain.
Its reaction center is located in the large interface between the two
domains, bringing together all components necessary to create an
acetyl radical that can be transferred onto the C5 position of U34
(5, 29, 30). In detail, an iron-sulfur cluster (FeS) coordinated in the
rSAM domain (4) is necessary to recruit SAM and initially creates
a 5′-deoxyadenosyl radical (5′-dA•) by reductive cleavage of
SAM. The KAT domain is essential for the binding of acetyl-CoA,
which is hydrolyzed upon tRNA binding (5). The heterohexameric
Elp456 subcomplex (25) that binds asymmetrically to one Elp123
lobe regulates its interaction with the tRNA via its adenosine
triphosphatase (ATPase) activity (25). As both Elp3 and Elp456
bind the tRNA anticodon stem loop (ASL), a sequential order of
tRNA binding events during the reaction cycle is assumed
(25, 27, 31). Moreover, the transient recruitment of accessory
proteins, including kinases and phosphatases, dynamically regulates
the Elongator modification cycle (13).
Despite increasing knowledge about the contribution of the 
individual subunits, high-resolution information of the Elp123 
subcomplex and its active site are missing. We and others have 
previously proposed structural models of the Elp123 subcomplex 
and Elongator via integrative modeling (26, 27). However, these 
architectural models were obtained in the absence of substrate 
tRNA and lacked detailed information of the intersubunit interactions 
and the active site itself. Moreover, as Elp123 holds two equivalent 
active sites, but Elp456 subcomplex binds exactly on top of only one 
Elp3 subunit, it is possible that tRNA binding and binding of Elp456 
to the same site are mutually exclusive. Here, we show cryo–electron 
microscopy (cryo-EM) structures of free and tRNA-bound Elp123 
at resolutions of 3.3 and 4.4 Å, respectively. Our results provide the 
structural framework for understanding substrate recognition and 
the modification reaction intermediates in molecular detail. Ultimately, 
it is of utmost importance to understand this highly conserved 
cellular machine to assess the consequences of clinically relevant 
Elongator mutations.
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RESULTS
Cryo-EM reveals the structure of Elp123 and its active site
Pure, stoichiometric, and homogeneous samples of endogenous 
yeast Elp123 subcomplex (fig. S1A) were stabilized with low concen-
trations of glutaraldehyde and vitrified to acquire cryo-EM images 
(fig. S1B). After classification and refinement, the dataset resulted 
in a map of Elp123 at a resolution of 4.5 Å (fig. S1C). The structure 
is composed of two lobes connected by an arch, as previously 
described by negative-stain EM (26). Flexibility between the two lobes 
was indicated by the partial alignment of the two-dimensional (2D) 
class-averages and the decreased local resolution in the arch. Thus, 
local refinement procedures, using differently masked areas of the 
lobe with and without the dimerization domain of Elp1 (Elp1-DD), 
yield improved resolutions of 3.7 Å for the Elp123 lobe including 
Elp1-DD and 3.3 Å without this region (fig. S1, D to G). Local 
amplitude scaling (LocScale) (32) of the Elp123 lobe maps was used 
to build and refine an atomic model of the Elp123 subcomplex 
(Fig. 1A and table S1).
The arrangement of the individual Elp1, Elp2, and Elp3 proteins 
in the Elp123 subcomplex confirms the previously proposed overall 
architecture (26, 27), although the good quality of the 3.3 Å resolution 
map allowed us to complete the full-length structure of Elp1 by de 
novo building (Fig. 1A). We determined the detailed structures of 
the yet unknown two WD40 domains: parts of the tetratricopeptide 
repeat (TPR) region and unanticipated loop regions (aa687–707 and 
aa807–854) absent from previous crystallographic studies (fig. S2A) 
(28). In addition, the map revealed the tight interaction network 
between the individual subunits in Elp123 that ensures the integrity 
of each lobe. In particular, Elp3 is tightly sandwiched between the 
double WD40 domains of Elp1 and Elp2. The central sheet of the 
KAT domain of Elp3 forms a continuous  sheet with the seventh 
blade of the second WD40 domain of Elp1, establishing a core 
interface that locks the relative orientation of these two modules 
(fig. S2B). Furthermore, the first WD40 domain of Elp2 connects to 
the Elp1 TPR region through the interaction of K250, L251, L253, 
and L254 in a groove formed by residues (L938, Q942, L952, Q956, 
Q959) in helices 14 and 15 of Elp1 (fig. S2C). As Elp2 shares a 
large interface with the rSAM domain of Elp3, it appears to be 
necessary to stabilize Elp3 and its active site throughout the modifi-
cation cycle.
Next, we compared the structures of the three subunits in the Elp123 
complex with the models obtained from the individual proteins in 
isolation using crystallography. The dimeric CTD of Elp1 shows a very 
similar conformation as in known crystal structures. The previously 
identified loop region implicated in tRNA binding (ScElp11176–1251) (33) 
remained unstructured (fig. S3A). In Elp2 (26, 34), two additional 
loops (aa242–254 and aa484–532) at the interface of Elp1 and Elp3 
subunits become clearly visible in the Elp123 lobe map (fig. S3B). The 
structure of yeast Elp3 (ScElp3) is highly similar to its bacterial counterpart 
(DmcElp3) (29) in the relative arrangement of the rSAM and KAT 
domains (fig. S3C), as well as the positioning of the conserved tRNA 
binding and KAT active site residues (Y540, Y541) (5, 23). ScElp3, 
in contrast to DmcElp3, does not harbor any zinc-binding motif 
(29), as two of the three responsible cysteine residues are absent in 
eukaryotic Elp3s. Instead, ScElp3 presents a helix (aa391–403) in 
this conserved region that points toward the central cavity. The FeS 
cluster organization in ScElp3 within the Elp123 complex is much 
more similar to other known rSAM enzymes (e.g., RlmN) (35, 36), 
and ScElp3 does not dimerize unlike DmcElp3 (fig. S3D).
Our reconstruction shows well-defined densities for the entire 
FeS cluster loop region, the FeS cluster itself, and a bound 5′dA 
molecule (i.e., product of the reductive SAM cleavage; Fig. 1B). 
Endogenous Elp123 harbors a cubic [4Fe4S] cluster that is coordinated 
by three strictly conserved cysteine residues (4, 23), namely, C108, 
C118, and C121 (Fig. 1B). Three cysteine residues contact three iron 
atoms of the cluster at an expected distance of ~2.1 Å, whereas an 
additional density surrounds the fourth iron atom that most likely 
represents bound methionine originating from SAM cleavage like 
in RlmN (36). 5′dA is accommodated by conserved residues (Y120, 
H293, M295, Y327, and L330) that specifically contact the ligand 
(Fig. 1B). In summary, our data demonstrate that the [4Fe4S] cluster 
coordination and SAM binding in Elongator are very similar to those 
in other rSAM proteins (37) and that they can occur in the absence 
of tRNA binding, as suggested earlier (4, 29).
Elp123 binds tRNA through Elp1 and Elp3
As the previously described tRNA binding sites in Elp1 and Elp3 are 
fully accessible in our structure, we asked whether tRNA binds 
directly to the Elp123 subcomplex even in the absence of Elp456. 
We observed a very strong interaction between endogenous Elp123 
and purified in vitro–transcribed Cy5-labeled yeast tRNAAlaUGC 
using electrophoretic mobility shift assay (EMSA) and microscale 
thermophoresis (Fig. 2, A and B). Given the high affinity and detrimental 
effects of glutaraldehyde for the complex formation (Fig. 2A), we 
incubated endogenous Elp123 with yeast tRNAAlaUGC to image the 
complex by cryo-EM without additional stabilization. After classification, 
an extra density matching the size and shape of tRNA was detectable 
in a fraction of particles (Fig. 2C and fig. S4, A to E). The structure 
of the Elp123-tRNA lobe solved at an overall resolution of 4.4 Å 
allowed the unambiguous fit of a tRNAAlaUGC model in the extra 
density, applying a systematic fitting procedure described previously 
(fig. S4, F and G) (26). Flexible fitting of the subunits and the tRNAAlaUGC 
ASL allowed us to build and refine an atomic model of the tRNA- 
bound Elp123 complex (Fig. 2, C and D). Our structure shows how 
the tRNA binds to the core of the Elp123 lobe by anchoring its ASL 
in the Elp3 active site and its T loop to the Elp1 CTD, exposing the 
partially flexible acceptor stem to the surrounding solvent (Fig. 2D). 
The comparison between the atomic models of the Elp123 lobe with 
and without the tRNA showed that Elp2 is slightly displaced toward 
Elp3 upon tRNA binding and that the first WD40 domain and 
the DD region of Elp1 move toward the tRNA, leading to a slight 
compaction of the Elp123 subcomplex (Fig. 3A and movie S1). These 
conformational changes perfectly coincide with flexible regions 
showing lower local resolution (fig. S4D). Considering the twofold 
symmetry of the Elp123 subcomplex, the accessibility of its active 
sites, and the asymmetric interaction of the Elp456 subcomplex, it 
remains unknown whether two tRNAs could be bound by Elp123. 
By performing particle subtraction and classification, we identified 
a set of particles that show two symmetric densities in both lobes of 
the Elp123 subcomplex (Fig. 3B and fig. S5, A to C). This pool of 
particles yielded a C2-symmetrized map at a resolution of 6.7 Å, 
in which the tRNA position is identical to that observed in the 
Elp123-tRNA lobe structure. Hence, we show that two tRNAs can 
bind simultaneously to the Elp123 subcomplex.
Anticodon interactions on Elp3 active site
Despite the compaction of the Elp123 subcomplex upon tRNA 
binding, the structure of Elp3 did not change markedly (Fig. 4A). 
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Fig. 1. Cryo-EM structure of yeast Elp123 showing its active site. (A) Atomic model of Elp123 shown from front and top. The FeS cluster (orange and yellow) and the 
5′dA molecule (green) are highlighted. Elp1, Elp2, and Elp3 domain organization is shown schematically and labeled in the upper panel. Scale bar, 25 Å. (B) Close-up of 
the active site of Elp3. Model and respective density of the [4Fe4S] cluster and the 5′dA molecule are shown. The coordinating cysteine residues are labeled, and the 
additional density next to the fourth iron atom is indicated by a question mark (upper left). Residues involved in FeS cluster and SAM coordination are shown with their 
respective densities (lower left). Organization of the active site including ligands and involved protein residues (right).
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Fig. 2. Cryo-EM structure of Elp123 bound to tRNAAlaUGC. (A) EMSA assay using endogenous Elp123 (left), recombinant Elongator (right), and fluorescently labeled 
tRNAAlaUGC in the presence of different concentrations of glutaraldehyde. The positions of free tRNA and protein-tRNA complexes (*) are indicated next to the native 
polyacrylamide gel electrophoresis (PAGE). (B) Representative microscale thermophoresis measurements, respective fits, and calculated dissociation constant (Kd) values 
for Elp123 (blue) and Elongator (green). In both cases, the Hill coefficient is close to 1, indicating the presence of independent binding sites. n = 3. (C) Atomic model of 
Elp123 lobe bound to tRNA (Elp1, orange; Elp2, yellow; Elp3, violet) showing additional electron density for tRNA at a resolution of 4.4 Å. The fitted tRNAAlaUGC model is 
colored in accordance to the scheme on the right [purple, acceptor stem (Acc); red, D-loop (DL); blue, ASL; orange, variable loop (VL); green, T-loop (TL)]. Close-up view 
highlighting the phosphate backbone of the VL and ASL following the density (bottom right). (D) Atomic model of Elp123-tRNA from different perspectives.
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The density for the [4Fe4S] cluster in the Elp123-tRNA complex is 
very distinct, but the density for SAM (or 5′dA) is harder to assess 
because the ligand is only partially occupied or even absent. The 
orientation of most of the residues involved in the FeS cluster and 
SAM coordination appears unchanged after tRNA binding (Fig. 4B). 
As much as can be judged at the nominal resolution, only R376, 
which is located directly between U34 and 5′dA, appears to protrude 
deeper into the reaction pocket, where it also affects the orientation 
of Y120 (fig. S5D). However, the bound tRNA molecule undergoes 
strong structural deformations in the ASL region by anchoring to 
Elp3 (Fig. 4C). Binding to Elp123 disturbs the typical stair-stepped 
conformation of the anticodon, positioning the U34 RNA base 
directly above the channel, leading to the active site (Fig. 4D). These 
ASL changes are typically found in tRNA structures that bound to 
modification enzymes (36, 38), guaranteeing specific access to the 
modified base. The ASL bases are held in position by previously 
identified basic residues (e.g., R145, R160, K325, R373, R393, and 
R411) (29), which are highly conserved among Elp3 proteins from 
different domains of life. Additional densities also contacting the tRNA 
were identified, but not of good enough quality to unambiguously 
trace the protein backbone. We assume that they represent a specific 
loop region in the Elp1-CTD and the N terminus of Elp3, which both 
might get partially structured upon tRNA binding. In accordance, 
we show that a purified Elongator complex lacking the Elp1-CTD 
loop region shows strongly reduced tRNA binding affinity (fig. S5E) 
and that the purified N terminus of Elp3 (aa1–95) binds to different 
tRNAs by itself (fig. S5F).
Functional characterization of Elp123
Next, we tested whether purified endogenous Elp123 and recombinant 
Elongator show tRNA-dependent acetyl-CoA hydrolysis activity, 
similar to archaeal Elp3 (5). Isolated bulk tRNA from wild-type or 
an elp3 deletion strain (i.e., endogenously modified tRNAs missing 
only Elongator-associated modifications) strongly increased acetyl- 
CoA hydrolysis in Elp123, showing a correlation between substrate 
recognition and induction of acetyl-CoA hydrolysis. However, using 
in vitro–transcribed tRNAAlaUGC, the hydrolysis activity was almost 
undetectable, indicating that unmodified tRNAs do not efficiently 
stimulate acetyl-CoA hydrolysis (Fig. 5A). These results might also 
point to the interplay of different tRNA modifications in the stimu-
lation of Elongator activity, as suggested for other modification 
enzymes (39). We thus used the acetyl-CoA hydrolysis assay to 
monitor one of the first steps of the reaction without the need of 
other proteins that are crucial for the tRNA modification reaction 
(e.g., Kti proteins).
Furthermore, on the basis of our structures, we tested a variety of 
deleted, truncated, and mutated versions of yeast Elongator using 
established phenotypical assays sampling tRNA modification defects 
in vivo (Fig. 5, B and C; fig. S6A; and table S2). In detail, we mutated 
active site residues on Elp3 (C118S/C121S, Y327, R376A, Y540A; 
Figs. 1B and 5B) and tRNA binding loops on Elp1 and Elp3 
(aa1176–1251 and aa1–93, respectively; Fig. 5B and fig. S5, E and F), 
two newly described helices in the proximity of tRNA (Elp3, aa391–
403; Elp1, aa811–853; Fig. 5B and fig. S3C), the Elp2 loop–contacting 
Elp1 (aa245–254; fig. S2C), and previously unknown Elp1 regions 
(aa1–17 and aa184–217; Fig. 5B). Although none of the mutations 
affected complex integrity (fig. S6B), all the mutants except the 
Elp1 helix and the loop-connecting Elp2 and Elp1 caused loss of 
Elongator function in vivo. These results confirm the functional 
relevance and importance of the residues, which are visible in our 
structures and evidently involved in tRNA recruitment, SAM binding, 
[4Fe4S] coordination, and acetyl-CoA hydrolysis. Last, this analysis 
also rationalizes the importance of previously suggested phospho-
rylation sites located in the Elp1-CTD and the N terminus of Elp3 for 
tRNA modification activity (29, 40). However, we cannot exclude 
that some of the essential regions tested might as well bind to acces-
sory cofactors such as Kti11, Kti12, and Kti14, as they are also involved 
in the final modification steps in vivo (13).
DISCUSSION
The atomic models of eukaryotic Elp123 and tRNA-bound Elp123 
revealed the molecular details of the Elongator active site, showing 
that the [4Fe4S] cluster bound to the 5′dA molecule. The tRNA-bound 
Elp123 structure reveals the tRNA anticodon deformation and the 
positioning of the modifiable U34 base upon interaction with Elp3. 
Moreover, the tRNA binding stimulates the acetyl-CoA hydrolysis in 
Elp123 but shows weaker stimulation with full Elongator. Therefore, 
our structural and functional analyses allow us to suggest a scheme 
of the modification reaction carried out by the eukaryotic Elongator 
complex. In detail, the two individual reactions, leading to (i) 5′dA 
in the rSAM domain and (ii) an activated acetyl group in the KAT 
domain, can proceed independently and get interconnected by the 
incoming tRNA substrate (Fig. 6A). The [4Fe4S] cluster supplies the 
requisite electron for reductive cleavage of SAM, which generates 
a 5′-dA• radical required for subsequent reaction steps (30). In 
addition, tRNA binding triggers acetyl-CoA hydrolysis, suggesting 
that the acetyl group moves from the KAT domain into the proximity 
of 5′-dA• and U34, where it can get converted into an acetyl radical. 
In this scenario, highly reactive radical intermediates would be 
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transferred over very short distances, minimizing the risk of unspecific 
acetylation events and by-products (Fig. 6A). Our proposed reaction 
scheme provides a structural rationale for the transfer of an acetyl 
radical to the U34 base located in close proximity.
We showed that Elp123 is able to bind one or two tRNAs with 
substantially higher affinity than the Elp456 subcomplex or the full 
complex, thereby favoring the idea that tRNAs are first attracted to 
Elp123 alone. In addition, the lower affinity to the full Elongator 
complex is accompanied by a lower tRNA-induced acetyl-CoA 
hydrolysis activity of the full complex. The binding of tRNA generates 
a compaction in the Elp123 subcomplex due to the movement of 
Elp1 (both DD and first WD40 domain) and Elp2 toward the tRNA, 
while Elp3 does not seem to change its conformation (see movie 
S1). The observed rearrangement of Elp1-CTD in both lobes, even 
if only one lobe is occupied by a tRNA molecule at a time, suggests 
a parallel regulatory mechanism in both Elp123 lobes. It seems 
unlikely that the Elp1 CTDs can move independently from each 
other, but it remains to be shown whether the asymmetrically 
bound Elp456 ring could mediate such behavior (Fig. 6B).
Using a phenotypical assay, we mapped the specific Elp123 
regions that are essential for the tRNA modification in vivo. Moreover, 
the good agreement between our previous negative-stain reconstructions 
and new high-resolution cryo-EM maps allowed us to assess the 
position of an Elp123-bound tRNA in relation to the Elp456 subcomplex 
within Elongator (Fig. 6C). The proposed interfaces with Elp456 
perfectly match previous cross-linking–mass spectrometry results 
among these regions in Elp3 and Elp1 and several residues of Elp4 
and Elp6 (26). In our tRNA-bound Elongator model, the spatial 
overlap between tRNA and Elp456 is relatively small, but the ring 
contacts the two anchoring points of the tRNA in Elp123, namely, 
the Elp3 active site and the Elp1-CTD loop (Fig. 6D). This, together 
with the increased binding of tRNA by Elp123 in the absence of 
Elp456, strongly suggests that the role of Elp456 in eukaryotes is 
rather related to active site clearance and efficient cm5-modified 
tRNA removal than to tRNA delivery or contributing directly to the 
modification reaction. In addition, we and others (25, 27) have 
previously shown that Elp456 binding to tRNA is regulated by its 
intrinsic ATPase activity. Notably, we observed reduced tRNA 
binding to the Elongator complex in the presence of adenosine 
triphosphate (ATP), whereas addition of SAM and acetyl-CoA does 
not affect tRNA release (fig. S6C). Hence, it has to be analyzed in the 
future whether ATP hydrolysis triggers the dissociation of tRNA-bound 
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Elp456 or releases the tRNA from Elongator after the modification 
reaction has been performed. In summary, our structural and 
functional analyses of Elp123 provide a comprehensive picture of the 
eukaryotic Elongator at the molecular level and clarify its mechanisms 
of substrate tRNA recognition.
MATERIALS AND METHODS
Sample preparation
Saccharomyces cerevisiae strain SCCM49 (MATa; his31; leu20; 
met150, ura30; YLR384C-3xFLAG::natNT2), the Elp1-3xFLAG 
strain, was generated by integrating a cassette of the 3xFLAG tag 
and a natNT2 marker into the genome of the parental strain BY4741. 
Yeast cells were grown as described previously (26). Cells (350 to 400 g) 
expressing C terminally FLAG-tagged Elp1 were suspended in buffer 
A [250 mM Hepes (pH 7.9), 125 mM NaCl, 0.1% NP-40, 10% glycerol, 
50 mM NaF, 0.1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride 
(PMSF)] supplemented with protease inhibitor cocktail (cOmplete 
EDTA-free, Roche) and lysed at 4°C with glass beads in BeadBeater 
(BioSpec). The soluble fraction obtained after centrifugation (1 hour at 
30,000g in a Beckman JA-14 rotor) was incubated with 5 ml of preequil-
ibrated ANTI-FLAG M2 affinity gel (Sigma-Aldrich) for 2 to 3 hours 
at 4°C. After washing the M2 resin with buffer B [10 mM Hepes (pH 7.9), 
125 mM NaCl, 0.1% NP-40, 10% glycerol, 50 mM NaF, 0.1 mM Na3VO4, 
1 mM PMSF supplemented with protease inhibitor cocktail] and buffer 
C [10 mM Hepes (pH 7.9), 125 mM NaCl, 10% glycerol, 50 mM NaF, 
0.1 mM Na3VO4], bound Elp123 was eluted in buffer C containing 
3× FLAG peptide (0.1 mg/ml; Sigma-Aldrich). A final concentration 
of 5 mM 2-mercaptoethanol was added to the eluate. The sample was 
concentrated to 7 to 20 mg/ml and subjected to a final purification 
step using a Superose 6 Increase 3.2/300 column (GE Healthcare) in 
buffer D [10 mM Hepes (pH 7.9), 125 mM NaCl, 50 mM NaF, 0.1 mM 
Na3VO4, 5 mM 2-mercaptoethanol] or buffer E [10 mM Hepes (pH 7.9), 
125 mM NaCl, 50 mM NaF, 0.1 mM Na3VO4, 5 mM dithiothreitol 
(DTT), 5 mM MgCl2]. For the apoElp123 reconstruction, the gel 
filtration was performed in buffer D. Purified Elp123 was incubated 
with in vitro–transcribed S. cerevisiae tRNAAlaUGC at a 1:3 molar 
ratio for 30 min at 25°C in the presence of 1 mM MgCl2 and 1 mM 
acetyl-CoA. The sample was cross-linked with 0.01% glutaraldehyde 
(Electron Microscopy Sciences) for 1 hour at 4°C, quenched with 40 mM 
tris-HCl buffer (final concentration) for 10 min, and then plunged. 
Following tRNA binding, experiments showed that Elp123 binding to 
tRNA was abolished in the presence of 0.01% glutaraldehyde (fig. S4A), 
validating the observation of apoElp123 but not Elp123-tRNA complexes 
in the cross-linked sample. Hence, for the Elp123-tRNA complexes, 
pure Elp123 (from gel filtration in buffer E) was incubated with 
in vitro–transcribed tRNAAlaUGC at a 1:5 molar ratio for 30 min at 
25°C (in the presence of 1 mM acetyl-CoA for the Elp123-tRNA 
lobe dataset and without acetyl-CoA for the Elp123-2tRNA dataset) 
and then immediately plunged.
Electron microscopy
Quantifoil grids (200 mesh 2/1 copper) were glow-discharged on a 
PELCO easiGlow glow discharger. A total of 2.5 l of sample (0.37 to 
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0.4 mg/ml) was plunge-frozen using FEI Vitrobot Mark IV set to 
100% humidity and 4°C (blotting parameters: wait time, 15 s; blot 
force, 5; blot time, 5 to 8 s). Micrographs were acquired at 300 kV 
using FEI Titan Krios equipped with a Gatan Quantum energy filter 
and a K2 Summit direct detector. The detector was operated in 
super-resolution mode at ×105,000 magnification, resulting in a pixel 
size of 0.675 Å on the object scale. A total of 4614 micrographs were 
collected for the apoElp123 reconstruction, 6990 for the Elp123-tRNA 
lobe reconstruction, and 5412 for the Elp123-2tRNAs reconstruction. 
We collected at under-focus varying between 1 and 2.5 m a total of 
40 frames accumulating to doses of 43 e−/Å2 (apoElp123), 44 e−/Å2 
(Elp123-tRNA lobe), and 39.8 e−/Å2 (Elp123-2tRNAs).
Image processing
Frame alignment and dose weighting were performed with MotionCor2 
(using Fourier space cropping by a factor of 2, resulting in a pixel 
size of 1.35 Å) (41), and contrast transfer function was determined 
with CTFIND4 (42). Initially, 8563 (apoElp123), 10888 (Elp123-tRNA 
lobe), and 9757 (Elp123-2tRNAs) particles were manually selected 
using EMAN2 boxer swarm tool (43). 2D classes obtained from these 
subsets in RELION2 (44) were used as templates in the autopicking 
procedure with the full datasets. Classification, refinement, post- 
processing, and local resolution estimation were performed with 
RELION2.
For the Elp123 structure, 1 million autopicked particles were 
extracted and binned four times to reduce computational costs (fig. S1G). 
These particles were subjected to reference-free classification, from 
which 490,000 particles (49%) were selected for subsequent processing. 
3D classification was performed with the selected unbinned particles 
using as a starting model the available Elp123 map at a resolution of 
27 Å (EMD-4151) low pass–filtered to 60 Å. Three classes (containing 
32% of the particles) were selected on the basis of their recognizable 
Elp123-like shape and subjected to a second round of 3D classification, 
using either a mask that covered one lobe of the Elp123 subcomplex 
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(for the Elp123 lobe map) or a mask covering the whole Elp123 
subcomplex [for the Elp123 lobe DD map]. For the Elp123 lobe, the 
classification with the lobe mask yielded two classes that showed 
better resolution and gathered 54% of the particles, which were 
pooled and refined using a lobe mask. We obtained the Elp123 lobe 
map with a resolution of 3.4 Å and 84,135 particles, which after 
post-processing yielded the final 3.3 Å resolution map. For the 
Elp123 lobe DD, the classification using a full mask yielded two 
classes with both lobes nicely defined, so we pooled the 81,709 
particles and then refined them using a mask covering the whole 
molecule that yielded the Elp123 lobe DD map at a resolution of 
3.97 Å. The post-processing of this map yielded a final 3.7 Å resolution 
map that included well-resolved Elp1-DD. Alternatively, for the Elp123 
full map, after the first round of 3D classification, we selected the 
best resolution class that showed an apparent twofold symmetry 
axis, although no symmetry was previously imposed. This class (with 
45,236 particles) was refined with C2 symmetry, applying a mask 
that covered the whole molecule. This procedure yielded the Elp123 
full map at a resolution of 7.5 Å, which was post-processed, yielding 
the final map at a resolution of 4.5 Å.
For the Elp123-tRNA lobe reconstruction (fig. S4F), 1.5 million 
particles were autopicked, extracted with bin 4, and reference-free–
classified. A total of 751,000 particles (50%) were selected and subjected 
to 3D classification using the same starting model as for apoElp123, 
the available 27 Å map of Elp123 (EMD-4151) low pass–filtered to 
60 Å as a reference. Two classes (that gathered 194,000 particles) 
were selected on the basis of their Elp123-like shape and the presence 
of an extra density on one or two lobes of the molecule.
The unbinned particles were used for a second round of 3D 
classification, yielding a good class of 65,000 particles with a conspic-
uous extra density on one lobe. A subsequent focused 3D classification 
step was performed after partial signal subtraction of the lobe (45). 
Only the signal coming from the extra density was considered, and 
masked 3D classification without alignment was performed yielding 
one class with a tRNA-shaped density in the lobe. This class 
with 23,020 particles was refined using a lobe mask, yielding an 
Elp123-tRNA lobe map at a resolution of 4.5 Å. The final map after 
post-processing was obtained at a resolution of 4.4 Å.
For the Elp123-2tRNA complex (fig. S6C), 798,000 autopicked 
particles were extracted, binned four times, and subjected to reference- 
free classification, from which 654,000 particles (82%) were selected. 
3D classification was performed with the subset of binned particles 
using the Elp123 map (EMD-4151) low pass–filtered to 60 Å. Two 
classes were selected on the basis of their Elp123-like shape and the 
presence of an extra density on one or two lobes of the molecule. 
The unbinned 189,000 particles from the two classes were subjected 
to a second round of 3D classification. One class with 52,000 particles 
was selected on the basis of the presence of a strong extra density on 
each lobe. This subset of particles was subjected to partial signal 
subtraction of the two lobes. Then, masked 3D classification without 
alignment was performed, yielding two classes with extra densities 
in both lobes. The 12,921 particles from these classes were pooled 
and refined independently with and without C2 symmetry, using a 
mask covering the whole molecule and yielding two equivalent 
reconstructions at resolutions of 7.8 Å (without symmetry) and 
6.9 Å (with C2 symmetry) (fig. S6A). The Elp123-2tRNA recon-
structions were post-processed, yielding the final 7.6 Å resolution 
map (without symmetry) and the 6.7 Å resolution map (with C2 
symmetry).
Model building
The building of initial models into the experimental density maps 
was guided by the available crystal structure of Elp2 [Protein Data 
Bank (PDB) ID, 5M2N], the crystal structure of the Elp1 CTD (PDB 
ID, 5CQS), as well as the homology models of Elongator subunits 
Elp1 and Elp3 described previously (26). For initial model building, 
the models were placed into the apoElp123 lobe map at a resolution 
of 3.3 Å by rigid body fitting in Chimera (46), and this initial model 
was used for the first round of LocScale (see below). The fitted 
structures of individual subunits were used to aid de novo model 
building and rebuilding reference models in the LocScale maps 
using Coot (47). In detail, the WD40 domains of Elp1 were only 
used for the generation of the first LocScale map, as they were 
regarded as low quality with the confident assignment of the fold 
but uncertain sequence register. Thus, both WD40 domains of Elp1 
were built de novo, aided by secondary structure prediction and 
side-chain densities in this region of the apoElp123 lobe map (fig. S2). 
The fit of the Elp1 CTD was optimized by flexible fitting of the crystal 
structure (PDB 5CQS) using iMODfit (48) until convergence of 
cross-correlation below a threshold of 0.00001 over 5000 steps (with 
maximum 100,000 steps) and refined in Coot in regions with good 
enough map quality. Before the fitting, missing side chains were 
added with Modeller (49), and the stereochemistry was refined with 
energy minimization using GROMACS (50). To prevent overfitting 
during the flexible fitting, constraints on the secondary structure 
were applied. Moreover, overfitting was controlled by comparing 
the resulting models with the rigid body fragments of the starting 
crystal structure of the Elp1 CTD (PDB ID, 5CQS), ensuring that 
relative arrangements of secondary structure elements are locally 
preserved and that side chains are similar to the starting structure. 
Moreover, we extended the Elp1 structure with the “link loop” (residues 
811 to 853), which was predicted on a secondary structure level and 
perfectly followed a prominent density. In addition, the Elp3 structure 
was extended with the helix (residues, 392 to 403) that was clearly 
visible in the cryo-EM density (apoElp123 lobe map) showing side-chain 
density and was also predicted on a secondary structure level. Our 
current model of apoElp123 accounts for most features observed in 
the experimental EM density maps (Elp123 lobe, Elp123 lobe DD, 
and full Elp123), including two strong densities located close to 
the active site that corresponds to the [4Fe4S] cluster and the 5′dA 
molecule.
tRNA-bound models were generated by flexible fitting of 
the apoElp123 model using iMODFit until convergence (with the 
convergence achieved in less than 500,000 steps). To identify the 
optimal fit of the tRNA and to select the template for comparative 
modeling of tRNAAlaUGC, fitting 802 tRNA chains available in the RNA 
Bricks database (51) to the segment of the EM map corresponding 
to the apparent tRNA density. For each structure, the fitting was 
performed using the University of California, San Francisco (UCSF) 
Chimera (46) global search with 10,000 random initial positions 
and normalized cross-correlation as the fitting metric. The statistical 
significance of the fits was assessed as a P value calculated from the 
normalized cross-correlation scores. To calculate the P values, the 
cross-correlation scores were first transformed to z scores (Fisher’s 
z transform) and centered, from which two-sided P values were 
computed using standard deviation derived from an empirical null 
distribution [derived from all obtained fits and fitted using fdrtool 
(52) from the R package] (53, 54). All P values were corrected for 
multiple testing using the Benjamini-Hochberg procedure, with the 
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number of tests corresponding to all resulting fits from all 802 structures 
(i.e., treating each fitting attempt from a random initial position as 
an independent test). From the top fits, the structure of tRNA-Glu 
that bound to RlmN methyltransferase (PDB ID, 5HR6, chain D) was 
selected as the modeling template. This structure and the corresponding 
fit ranked first according to the normalized cross-correlation score 
(adjusted P = 6 × 10−7). The comparative model based on this template 
was built using ModeRNA (55). The G:U base pair 50–64 of the model 
was further refined using SimRNA (56) to recapitulate appropriate 
hydrogen bond interactions, and the final models were minimized 
using GROMACS (50). Note that because of limitations of comparative 
modeling and limited resolution of the tRNA density, the comparative 
model of the tRNA-Ala should be regarded with caution with deviations 
from the true structure expected, particularly in the regions of D- and 
T-loop and the acceptor stem. These deviations are not expected to 
affect the overall fit and the anticodon loop, where the quality of the 
density is sufficient for de novo tracing. The comparative model was 
fitted into the Elp123-tRNA density map at a resolution of 4.4 Å by 
superposition onto the template fitted as described above and local 
optimization using “Fit in Map” tool of UCSF Chimera. The anticodon 
loop was built de novo by manual building in Coot.
Local amplitude scaling
To generate the LocScale maps, unsharpened and unfiltered cryo-EM 
maps were scaled against simulated model maps using a rolling 
window of 20 voxels. The model maps were simulated from full-chain 
models refined against cryo-EM maps that were sharpened in RELION2. 
The dmin parameter of the LocScale procedure was set to the Nyquist 
frequency (2.7 Å), as recommended by the authors (32). Two rounds 
of LocScale were performed for the Elp123 lobe map, and one round 
was performed for the Elp123 lobe DD map.
Model refinement and validation
Models were refined against respective cryo-EM maps, which were 
B factor–sharpened with RELION2’s post-process tool. Automated 
real-space refinement cycles were alternated with manual model 
building in Coot. Manual model building was aided by experimental 
maps filtered at lower resolution and LocScale maps. Geometry statistics 
were calculated with MolProbity (57). Figures were prepared using 
PyMOL (58) and Chimera (46).
tRNA preparation
S. cerevisiae tRNAAlaUGC was in vitro–transcribed by T7 RNA poly-
merase from a linearized pUC19 vector harboring a corresponding 
tRNA sequence under the control of a T7 promoter. Transcription 
took place overnight at 37°C in 20 mM tris-HCl (pH 8.0), 150 mM 
NaCl, 8 mM MgCl2, 2 mM spermidine, template DNA (100 g/ml), 
RNasin (25 mg/ml), pyrophosphatase (0.001 U/ml), and T7 
RNA polymerase. To modify tRNA internally with Cy5 dye during 
transcription, 20% of cytidine triphosphate was substituted with 
5-propargylamino-cytidine-5′-triphosphate labeled with Cy5 (Jena 
Bioscience). Deoxyribonuclease (3 to 10 U; Thermo Fisher Scientific) 
was added for 30 min at 37°C to remove template DNA followed by 
purification on HiTrap DEAE FF column (GE Healthcare). tRNA 
eluate was precipitated overnight at −20°C with 0.3 M sodium acetate 
(pH 5.5) and 75% ethanol. After centrifugation for 30 min at 4°C 
(20,000g), the tRNA pellet was washed with 75% ethanol; dried and 
suspended in 20 mM Hepes (pH 7.5), 50 mM NaCl, and 50 mM 
KCl; and annealed by gradual cooling from 80° to 40°C at a speed of 
0.5°C/min. After annealing, tRNA was supplemented with 1 mM 
MgCl2 and 1 mM DTT and purified on a Superdex 75 Increase 
10/300 GL column (GE Healthcare).
Wild-type bulk tRNA and bulk elp3 tRNA were purified from 
UMY2893 and UMY2916 strains, respectively. Cells were grown in 
yeast extract/peptone/dextrose (YPD) medium to an OD600 (optical 
density at 600 nm) of 1.0 to 1.5, collected by centrifugation, and 
suspended in equal volume of 10 mM tris-HCl (pH 7.5), 1 mM EDTA, 
100 mM sodium acetate, and 1% SDS. After freezing in liquid nitrogen, 
cells were cryo-milled and thawed at 4°C with agitation. The lysate 
was mixed with equal volume of TRIzol (Thermo Fisher Scientific) 
and incubated at room temperature for 20 min. Next, 20% (v/v) of 
chloroform was added, mixed, and incubated at room temperature 
for 15 min. After centrifugation at 4°C with 3000g, the aqueous phase 
was collected and further centrifuged at 4°C for another 60 min at 
12,000g. Large RNA from the supernatant was precipitated by incubation 
at −20°C for 3 hours with 33% volume of 8 M lithium chloride and 
centrifugation at 4°C with 4000g (30 min). tRNA was precipitated 
as described above and suspended in 4 ml of 10 mM sodium acetate 
(pH 5.2). tRNA was purified on HiLoad 26/600 Superdex 200 pg 
(GE Healthcare). Both transcribed and bulk tRNAs were concentrated 
using an Amicon Ultra-0.5 3k concentrator (Merck Millipore), 
aliquoted, and stored at −20°C.
Recombinant protein production and purification
S. cerevisiae ELP1 to ELP6 genes were amplified in polymerase chain 
reactions (PCRs) and cloned in pairs into vectors with opposite-oriented, 
inducible GAL1 and GAL10 promoters to allow simultaneous expression 
of two genes from one vector (59). Each vector harbored different 
selection marker cassettes (LEU2, TRP1, and URA3) to ensure the 
exclusive growth of transformants. For the purpose of later protein 
purification, the ELP3 or ELP1 gene was modified with FLAG and 
Twin-Strep-tag (IBA Lifesciences) coding sequences, while the C 
terminus of Elp6 was fused to Staphylococcus aureus protein A and 
a cleavage site for the protease of tobacco etch virus (His-TEV). 
Elp1, Elp2, and Elp3 mutant proteins were prepared by mutating 
respective genes in modified QuikChange reactions. DS1-2b yeast strain 
was cotransformed with vectors carrying ELP genes. Transformants were 
grown on selection medium agar plates. To overproduce Elongator, 
transformed cells were grown at 30°C with shaking in raffinose 
selection medium to an OD600 of 0.3 to 0.6 and induced for the 
following 21 hours with galactose at a 2% final concentration. Cells 
were next spun down, suspended in a lysis buffer [LB; 250 mM 
Hepes (pH 7.5), 100 mM NaCl, 10% glycerol, 0.1% Tween 20, 1 mM 
sodium orthovanadate, 20 mM sodium fluoride, aprotinin (2 g/ml), 
leupeptin (5 g/ml), 1 M pepstatin A, and 1 mM PMSF; 3 ml of LB 
per 20 g of cell pellet], and frozen in liquid nitrogen in the form of 
small drops. Drops were lysed by cryo-milling to a powder on a 
Qiagen TissueLyser II instrument and stored at −80°C. All purification 
steps were performed at 4°C or on ice. To isolate recombinant wild-type 
and mutant forms of Elongator, 12 ml of LB was added per 24 to 26 g 
of yeast pellet and thawed for 1 hour with agitation. Lysates were clarified 
by centrifugation first at 7000g (30 min) followed by another round 
of centrifugation at 20,000g (20 min). Cell extracts were incubated 
with agitation for 30 min with 2 ml of immunoglobulin G Sepharose 
6 Fast Flow affinity resin (GE Healthcare), followed by two wash 
steps (10 ml). The bound fraction was incubated with 1 mg of His-TEV 
protease in the presence of 1 mM DTT for 1 hour and eluted. Next, 
Elongator was bound to a 1-ml StrepTrap HP column (GE Healthcare) 
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and eluted with 20 mM d-desthiobiotin. After concentrating on 
an Amicon Ultra-15 100k, Elongator was purified on a Superose 
6 Increase 10/300 GL column (GE Healthcare) equilibrated with 20 mM 
Hepes (pH 7.5) buffer, 100 mM NaCl, and 3 mM DTT. Selected 
fractions were pooled and concentrated to ~1 mg/ml with an Amicon 
Ultra-0.5 100k concentrator. Aliquots were frozen in liquid nitrogen 
and stored at −80°C.
tRNA binding assays
The internally Cy5 labeled tRNAAlaUGC (0.1 M) was incubated with 
endogenous yeast Elp123 subcomplex or recombinant wild-type or 
mutant forms of Elongator (0.1 to 0.9 M) for 10 min on ice. The 
reaction was carried out in the buffer condition containing 20 mM 
Hepes (pH 7.5), 100 mM NaCl, 5 mM MgCl2, and 3 mM DTT. Next, 
samples were supplemented with 30% glycerol and resolved on a tris-boric 
acid EDTA–based 6% native polyacrylamide gel electrophoresis 
(PAGE) gels containing 15% sucrose using EMSA. Gels were run 
with 120 V for 1 hour and 40 min in 1× tris-glycine/DTT buffer at 
4°C. Individual cofactors (1 mM), such as acetyl-CoA, SAM, and 
ATP, were added as indicated in figures. To quantify the tRNA 
binding affinity of Elp123 and Elongator, microscale thermophoresis 
assays were performed. The reactions (20 l) were carried out as 
described above and applied to premium capillaries (NanoTemper). 
The interactions were determined using the MO.Control software 
(NanoTemper), and dissociation constants (Kd’s) were calculated 
based on triplicate measurement using the MO.Affinity software 
(NanoTemper).
Acetyl-CoA hydrolysis assays
Acetyl-CoA hydrolysis rates were measured using the Acetyl-CoA 
Assay Kit (MAK039, Sigma-Aldrich). Endogenous yeast Elp123 
subcomplex or Elp3-compensated recombinant Elongator (108 nM) 
was mixed with 2 M tRNA (in vitro–transcribed yeast tRNAAlaUGC 
or bulk tRNA) in the presence of 100 M acetyl-CoA in 1× acetyl-CoA 
assay buffer. Next, samples were incubated in a thermocycler for 
185 min at 30°C, and proteins were removed using an Amicon Ultra-0.5 
column. The flow through was collected, and measurement of acetyl-CoA 
concentration was performed as indicated in the manual. The end-point 
assay was performed, and the fluorescence intensity (Excitation, 535 nm; 
Emission, 587 nm) was measured using a plate reader (Molecular Devices). 
Hydrolysis rates were calculated from at least three independent 
experiments.
Plasmid constructs
Plasmid carrying the c-myc3–tagged versions of wild-type and 
mutated alleles of the ScELP3 gene [ScELP3-(myc)3] are based on the 
centromeric plasmid p424TDH (60). The gene was amplified by PCR 
from genomic DNA using yeast strain FFY3t (ELP3-(myc)3::SpHIS5) 
as a template. The PCR fragment was cloned into p424TDH using 
Eco RI and Xho I to give pON34 (ELP3-(myc)3). pON34 served as a 
template to generate mutated elp3-(myc)3 alleles by using the QuikChange 
Site-Directed Mutagenesis Kit (Agilent Technologies) to construct 
the mutated versions elp3-H110A-(myc)3, elp3-C118A/C121A-(myc)3, 
elp3-V119A/Y120A-(myc)3, (elp3-Y136A-myc)3, elp3-R232A-(myc)3, 
elp3-R269A-(myc)3, elp3-H271A-(myc)3, and elp3-W341A-(myc)3. The 
other mutations were transferred from plasmids of the GAL-driven 
overexpression system. Plasmids carrying elp1_811-853 or elp3_1-93 
were generated using the In-Fusion HD Cloning Kit (Takara Bio 
USA Inc.). For elp1_811-853, two fragments were amplified by 
PCR from genomic DNA using yeast strain UMY2893. Fragment 1 was 
amplified using ELP1_pUC19-F (5′-CGACGGCCAGTGAATTCAT-
GGTTGAACATGACAAGAGTG-3′) and ELP1_d811-R (5′-TATTTTGTT-
GACTTTATCTTCCGACAAACAGGAAA-3′). Fragment 2 was amplified 
with the following oligonucleotides: ELP1_d853-F (5′-AAAGTCAA-
CAAAATATGCGATGCTGTGC-3′) and ELP1_pUC19-R (5′-ATTAC-
GCCAAGCTTGCATGCCTGCTGCTCAAAAATCAACAATAT-
GACTCTTAGGG-3′). For elp3_1-93, the first fragment was amplified 
using Elp3-pUC19-F (5′-CGACGGCCAGTGAATTCATCACTTATA-
ACGTTGTGTT-3′) and Elp3_d2-93_R (5′-CACTGCAATACCCG-
ACATCTTTGTCAGGGTGTTCTTCGA-3′) from pRZ130 (pJet200 
XbaI/XhoI + PELP3-elp3_E485A-3myc- SpHIS3-TermELP3) and 
the second fragment was amplified using Elp3_d2-93_F (5′-TCGG-
GTATTGCAGTGGTAGC-3′) and Elp3-pUC19-R (5′-CCAAGCTTG-
CATGCCTGCTGAATCTTCAAAATATATGTACGT-3′) from pRZ135 
(pJet200 XbaI/XhoI + PELP3-elp3_K86A-K88A-3myc-SpHIS3-TermELP3). 
Both fragments were cloned in the linearized (with EcoRI and SphI, 
respectively) plasmid pUC19 (61).
Phenotypical analyses of Elongator function in vivo
To analyze the presence of the Elongator-dependent tRNA anticodon 
modification in elp1, elp2, or elp3 mutants, two established assays 
were used: the zymocin sensitivity assay and the SUP4 suppression 
assay (62). Zymocin, a trimeric toxin secreted by so-called killer 
strains of Kluyveromyces lactis strains, inhibits growth of sensitive 
yeasts by cleaving tRNAs that contain mcm5s2U34-modified tRNA 
anticodons. Growth inhibition by zymocin in the growth medium 
or intracellular expression of the catalytic -toxin subunit of zymocin, 
a tRNA endonuclease, is abolished by mutations inactivating Elongator 
function. The SUP4 suppression assay makes use of the SUP4-encoded 
suppressor tRNA, which has an mcm5U34-modified anticodon. 
Strains carrying the SUP4 suppressor allele plus the ochre stop codon 
containing ade2-1 or can1-100 alleles provide convenient readouts 
for Elongator activity on medium lacking adenine or containing 
canavanine. The latter is a toxic arginine analog taken up by the 
arginine permease encoded by CAN1. Elongator deficiency results 
in canavanine resistance or adenine auxotrophy correlating with 
the degree of mcm5 modification. Zymocin or -toxin resistance 
reflects the Elongator-dependent mcm5s2 modification status. For 
the -toxin assay, the -toxin gene was expressed from the galactose- 
inducible GAL1 promoter on plasmid pLF16 (63). Transformed strains 
were grown overnight in single dropout medium lacking leucine, 
and serial dilutions of the cell suspensions were spotted on either 
2% dextrose–containing (repressing conditions) or 2% galactose–
containing (inducing conditions) plates and incubated for 3 days at 
30°C. In the zymocin or killer eclipse assay, the zymocin-producing 
K. lactis strain AWJ137 (64) was inoculated next to a drop of the 
S. cerevisiae strains to be tested (table S2). The plates were incubated 
at 30°C, and the growth inhibition zone around the killer strain was 
analyzed in the elp1, elp2, or elp3 mutants after 2 days. Alternatively, 
zymocin was provided by the supernatant of strain AWJ137 grown 
overnight in YPD.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/7/eaaw2326/DC1
Fig. S1 Elp123 cryo-EM reconstruction.
Fig. S2. Atomic structure of the Elp1 N terminus and intersubunit contacts.
Fig. S3. Structural comparison of individual Elongator subunits.
Fig. S4. Cryo-EM reconstruction of Elp123-tRNA.
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Fig. S5. Cryo-EM reconstruction of Elp123 bound to two tRNAs.
Fig. S6. In vivo and in vitro characterization of Elongator mutants.
Table S1. Collection and refinement statistics.
Table S2. Yeast strains used in this study.
Movie S1. Conformational changes of Elp123 upon tRNA binding.
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